NEXLIZET
Live / Registered — Registered (as of 13 Oct 2020)
What this means for you
Registered since 13 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88145092
- Registration number
- 6175773
- Mark type
- Stylized text
- Filed
- 05 Oct 2018
- Published for opposition
- 05 Mar 2019
- Registered
- 13 Oct 2020
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of metabolic disease
Owner
- Esperion Therapeutics, Inc., Ann Arbor, MI, US
- Esperion Therapeutics, Inc., Ann Arbor, MI, US
- Esperion Therapeutics, Inc., Ann Arbor, MI, US
Prosecution history
- 26 Feb 2026 — TEAS SECTION 8 & 15 RECEIVED
- 13 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 09 Sept 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Sept 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jul 2020 — USE AMENDMENT FILED
- 13 Aug 2020 — SOU EXTENSION 3 GRANTED
- 28 Jul 2020 — SOU EXTENSION 3 FILED
- 13 Aug 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 28 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
- 31 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2020 — SOU EXTENSION 2 GRANTED